Markus Meyer

University of Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (3)

Prabhjot Nijjar

University of Minnesota

UNITED STATES

View details

Michael Zile

Professor

Medical University of South Carolina

UNITED STATES

View details

Timothy Plante

Assistant Professor

Larner College of Medicine, University of Vermont

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markus Meyer

Research Interests

Explore related searches

Contact this professor

Articles (20)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP-HFpEF trial

Atrial fibrillation and heart failure with preserved ejection fraction “twindemic”—Shared root causes and treatment targets

Accelerated pacing as a treatment for heart failure with preserved ejection fraction and atrial fibrillation?

Aging diastole-root cause for atrial fibrillation and heart failure with preserved ejection fraction

Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction

Physiological Pacing for the Prevention and Treatment of Heart Failure

Personalized Accelerated Physiologic Dual Rate Pacing for Cardiac Amyloidosis

Bachmann bundle pacing

Personalized Pacing for HFpEF

Effect of Personalized Accelerated Pacing in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?

Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction—Profibrotic and Proinflammatory Pathways and Genes

Beta-blockers in atrial fibrillation—trying to make sense of unsettling results

Clinical impact of Bachmann's bundle pacing defined by electrocardiographic criteria on atrial arrhythmia outcomes

Heart rate changes and myocardial sodium

Bachmann bundle potential during atrial lead placement

Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)

Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction

Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry

A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone

Collaborators (3)

Prabhjot Nijjar

Michael Zile

Timothy Plante

Make your next move.